•Today, Biotalys provided a regulatory update on its pilot product EVOCA™, as well as on its next-gen product candidate: The EPA has granted full registration approval for EVOCA™, marking a historic regulatory milestone for BTLS.•With this approval, EVOCA™ becomes the first protein-based biocontrol to achieve full EPA registration. This breakthrough validates BTLS' platform & paves the way for the regulatory submission of next-generation (and to be commercialized) EVOCA™ - expected in the U.S. ' ....
